About Event
Welcome to the 4th Liquid Biopsy for Precision Oncology East Coast Summit
About the 4th Liquid Biopsy for Precision Oncology East Coast:
Returned to Boston in 2025, this exclusive forum was your once-a-year chance to connect with the pioneers driving real-world impact in precision oncology.
This is the only East Coast forum which offered a truly focused, high-value environment where deep learning and strategic networking translate into real change across pharma, diagnostics, and beyond.
With brand-new content exploring the role of liquid biopsy in ADCs, personalized cancer vaccines, RAS-mutant targeted therapies, circulating tumor cells, rare disease, and more, this Summit was your gateway to understanding how leading organizations are harnessing liquid biopsy across the full spectrum of clinical development are, and where the field is headed next.
What’s more? It was absolutely free*!
Top 5 Benefits of Attending in 2025:
Establish gold-standard frameworks for leveraging liquid biopsies to confidently translate liquid biopsy from trial to clinic, streamline decision-making, and overcome adoption barriers
Advance MRD as a powerful trial endpoint to reduce timelines, cut costs, and boost trial success by applying harmonized strategies for global implementation
Harness ctDNA to personalize dosing and disease monitoring to avoid overtreatment, reduce toxicity, and optimize therapy with practical tools to support realtime treatment decisions
Transform new modalities including ADCs and cancer vaccines development with liquid biopsies to improve patient selection, monitor response earlier, and enhance personalized treatment strategies
Navigate regulatory and commercial complexity to fast-track approvals, secure reimbursement, and drive successful clinical integration at scale
Who Could You Have Met?
This Summit brought an audience of 120+ senior decision makers and subject matter experts from pioneering biotech, leading pharma, and technology innovators.
